These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 33046351)

  • 1. Add-on benzodiazepine treatment in patients with major depressive disorder - results from a European cross-sectional multicenter study.
    Dold M; Bartova L; Fugger G; Mitschek MMM; Kautzky A; Frey R; Montgomery S; Zohar J; Mendlewicz J; Souery D; Fabbri C; Serretti A; Kasper S
    Eur Neuropsychopharmacol; 2020 Dec; 41():70-80. PubMed ID: 33046351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for excessive benzodiazepine use in a working age population: a nationwide 5-year survey in Norway.
    Fride Tvete I; Bjørner T; Skomedal T
    Scand J Prim Health Care; 2015; 33(4):252-9. PubMed ID: 26683285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and clinical correlates of benzodiazepine use in the patients with major depressive disorder.
    Wang C; Wang X; Wang J; Li X; Lu D; Guo F; Yao Y; Zhu J; Shen C; Xie Q; Mao H; Zhang P; Yang X; Wu H; Lv Q; Yi Z
    J Affect Disord; 2024 Oct; 363():619-625. PubMed ID: 39043307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical perspective on late-onset depression in European real-world treatment settings.
    Bartova L; Fugger G; Dold M; Kautzky A; Bairhuber I; Kloimstein P; Fanelli G; Zanardi R; Weidenauer A; Rujescu D; Souery D; Mendlewicz J; Zohar J; Montgomery S; Fabbri C; Serretti A; Kasper S
    Eur Neuropsychopharmacol; 2024 Jul; 84():59-68. PubMed ID: 38678879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of mirtazapine versus selective serotonin reuptake inhibitors on benzodiazepine use in patients with major depressive disorder: a pragmatic, multicenter, open-label, randomized, active-controlled, 24-week trial.
    Hashimoto T; Shiina A; Hasegawa T; Kimura H; Oda Y; Niitsu T; Ishikawa M; Tachibana M; Muneoka K; Matsuki S; Nakazato M; Iyo M
    Ann Gen Psychiatry; 2016; 15():27. PubMed ID: 27777607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world evidence from a retrospective study on suicide during depression: clinical characteristics, treatment patterns and disease burden.
    Wang H; Lyu N; Huang J; Fu B; Shang L; Yang F; Zhao Q; Wang G
    BMC Psychiatry; 2024 Apr; 24(1):300. PubMed ID: 38641767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzodiazepines for Treatment-Resistant Major Depressive Disorder and Obsessive-Compulsive Disorder With Comorbid Mega Cisterna Magna.
    Ismail A; Ab Razak A; Sayuti KA; Phoa PKA
    Cureus; 2023 Oct; 15(10):e46670. PubMed ID: 37942372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of vulva in lichen sclerosus increases the risk of antidepressant and benzodiazepine prescriptions for psychiatric disorder diagnoses.
    Choi UE; Nicholson RC; Agrawal P; Watts E; Kohn TP; Kohn JR; Clifton M
    Int J Impot Res; 2024 Sep; 36(6):641-646. PubMed ID: 37973860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressants plus benzodiazepines in major depressive disorder: a clinical dilemma with no recent answers from research.
    de Cates A; De Giorgi R
    BJPsych Adv; 2020 Nov; 26(6):321-326. PubMed ID: 34589233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation with antidepressants in schizophrenia treatment: benefit or risk.
    Mao YM; Zhang MD
    Neuropsychiatr Dis Treat; 2015; 11():701-13. PubMed ID: 25834445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and treatment outcomes of major depressive disorder with genital symptoms.
    Wu X; Zhu Y; Sun P; Wang S; Wu Z; Huang J; Cao L; Wang Y; Su Y; Yao Z; Wang Z; Wang F; Wang Y; Peng D; Chen J; Fang Y
    Chin Med J (Engl); 2024 Mar; 137(5):622-624. PubMed ID: 38282362
    [No Abstract]   [Full Text] [Related]  

  • 12. Does anxiety moderate the effectiveness of mirtazapine in patients with treatment-resistant depression? A secondary analysis of the MIR trial.
    Rifkin-Zybutz R; MacNeill S; Davies SJ; Dickens C; Campbell J; Anderson IM; Chew-Graham CA; Peters TJ; Lewis G; Wiles N; Kessler D
    J Psychopharmacol; 2020 Dec; 34(12):1342-1349. PubMed ID: 33143538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melancholic features in major depression - a European multicenter study.
    Dold M; Bartova L; Fugger G; Kautzky A; Mitschek MMM; Fabbri C; Montgomery S; Zohar J; Souery D; Mendlewicz J; Serretti A; Kasper S
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110285. PubMed ID: 33609603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconceptualising treatment-resistant depression as difficult-to-treat depression.
    McAllister-Williams RH; Arango C; Blier P; Demyttenaere K; Falkai P; Gorwood P; Hopwood M; Javed A; Kasper S; Malhi GS; Soares JC; Vieta E; Young AH; Papadopoulos A; Rush AJ
    Lancet Psychiatry; 2021 Jan; 8(1):14-15. PubMed ID: 33341160
    [No Abstract]   [Full Text] [Related]  

  • 15. Combining machine learning algorithms for prediction of antidepressant treatment response.
    Kautzky A; Möller HJ; Dold M; Bartova L; Seemüller F; Laux G; Riedel M; Gaebel W; Kasper S
    Acta Psychiatr Scand; 2021 Jan; 143(1):36-49. PubMed ID: 33141944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of corticosteroids therapy in patients with moderate to severe SARS-CoV-2 infection: a multicenter, randomized, open-label trial.
    Ghanei M; Solaymani-Dodaran M; Qazvini A; Ghazale AH; Setarehdan SA; Saadat SH; Ghobadi H; Hoseininia S; Elahikhah M; Samadi AH; Imani Y; Vahedi E; Babamahmoodi F; Rostami FT; Ardebili MHA; Ansarifar A; Golmaei FF; Asadollah A
    Respir Res; 2021 Sep; 22(1):245. PubMed ID: 34526033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Online information discrepancies regarding safety of medicine use during pregnancy and lactation: an IMI ConcePTION study.
    Nörby U; Noël-Cuppers B; Hristoskova S; Desai M; Härmark L; Steel M; El-Haddad C; Douarin L
    Expert Opin Drug Saf; 2021 Sep; 20(9):1117-1124. PubMed ID: 34080506
    [No Abstract]   [Full Text] [Related]  

  • 18. Low-Dose Triple Antihypertensive Combination Therapy in Patients with Hypertension: A Randomized, Double-Blind, Phase II Study.
    Hong SJ; Sung KC; Lim SW; Kim SY; Kim W; Shin J; Park S; Kim HY; Rhee MY;
    Drug Des Devel Ther; 2020; 14():5735-5746. PubMed ID: 33408462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Low-Dose Quetiapine in the Treatment of Somatic Symptom Disorder: A Case Report.
    Pagan Cruz S; Guiribitey PM; Shupe G
    Cureus; 2023 Dec; 15(12):e50116. PubMed ID: 38186501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pharmacovigilance approach for assessing the occurrence of suicide-related events induced by antiepileptic drugs using the Japanese adverse drug event report database.
    Koseki T; Horie M; Kumazawa S; Nakabayashi T; Yamada S
    Front Psychiatry; 2022; 13():1091386. PubMed ID: 36699485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.